Literature DB >> 16360150

Light-induced exacerbation of retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome.

Dana K Vaughan1, Neal S Peachey, Michael J Richards, Blake Buchan, Steven J Fliesler.   

Abstract

Potentiation of retinal degeneration by intense light exposure, and its amelioration by an antioxidant, were studied in a rat model of Smith-Lemli-Opitz syndrome (SLOS), in comparison with normal (control) Sprague-Dawley rats. The SLOS model is created by treating rats with AY9944, a selective inhibitor of cholesterol synthesis at the level of 3beta-hydroxysterol-Delta7-reductase. A subset of rats was treated with dimethylthiourea (DMTU), a synthetic antioxidant, 24 and 1 hr prior to light exposure. Half of the animals (+/-DMTU) were exposed to intense, constant, green light (24hr, 1700lx, 490-580 nm), while the others were maintained in darkness. Subsequently all animals were returned to dim cyclic light (20-40 lx, 12 hr light-12 hr dark) for 2 weeks, after which electroretinograms were recorded. One eye from each rat was taken for histological and quantitative morphometric analyses; sterol analysis was performed on retinas from contralateral eyes. HPLC analysis confirmed the accumulation of 7-dehydrocholesterol (7DHC) in retinas of AY9944-treated rats; cholesterol represented >99% of the sterol in control retinas. Histology of retinas from unexposed, AY9944-treated rats (6-week-old) was normal. In contrast, age-matched, light-exposed rats exhibited massive photoreceptor cell loss in both the superior and inferior hemispheres, and concomitant rod and cone dysfunction. The severity and geographic extent of the damage was far greater than that observed in normal albino rats exposed to the same conditions. DMTU pre-treatment largely prevented these degenerative changes. These findings indicate that the AY9944-induced rat SLOS model is hypersensitive to intense light-induced retinal damage, relative to normal rats. DMTU protection against light-induced damage implicates free radical-based oxidation in the retinal degeneration process. Furthermore, the use of green light (corresponding to the absorption maxima of rhodopsin) implicates rhodopsin in the initiation of the pathobiological mechanism. We propose that generation of cytotoxic oxysterols (by-products of 7DHC oxidation) is an integral part of retinal cell death in the SLOS rat model, which is exacerbated by intense light. Furthermore, the results predict light-dependent potentiation of retinal degeneration in SLOS patients, and the possible ameliorative effects of antioxidant therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16360150      PMCID: PMC2844790          DOI: 10.1016/j.exer.2005.08.008

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  46 in total

1.  Rod photoreceptor responses in children with Smith-Lemli-Opitz syndrome.

Authors:  Ellen R Elias; Ronald M Hansen; Mira Irons; Nicole B Quinn; Anne B Fulton
Journal:  Arch Ophthalmol       Date:  2003-12

Review 2.  Smith-Lemli-Opitz syndrome and the DHCR7 gene.

Authors:  P E Jira; H R Waterham; R J A Wanders; J A M Smeitink; R C A Sengers; R A Wevers
Journal:  Ann Hum Genet       Date:  2003-05       Impact factor: 1.670

3.  Prevention of thiourea-induced pulmonary edema by hydroxyl-radical scavengers.

Authors:  R B Fox; R N Harada; R M Tate; J E Repine
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-11

4.  Oxygen radical scavengers protect alveolar macrophages from hyperoxic injury in vitro.

Authors:  R N Harada; A E Vatter; J E Repine
Journal:  Am Rev Respir Dis       Date:  1983-10

5.  Five-year incidence of age-related maculopathy in relation to iris, skin or hair colour, and skin sun sensitivity: the Blue Mountains Eye Study.

Authors:  Jie Jin Wang; Kirsten Jakobsen; Wayne Smith; Paul Mitchell
Journal:  Clin Exp Ophthalmol       Date:  2003-08       Impact factor: 4.207

6.  Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study.

Authors:  Sandra C Tomany; Karen J Cruickshanks; Ronald Klein; Barbara E K Klein; Michael D Knudtson
Journal:  Arch Ophthalmol       Date:  2004-05

7.  Ocular manifestations of the Smith-Lemli-Opitz syndrome.

Authors:  F L Kretzer; H M Hittner; R S Mehta
Journal:  Arch Ophthalmol       Date:  1981-11

Review 8.  Do blue light filters confer protection against age-related macular degeneration?

Authors:  T H Margrain; M Boulton; J Marshall; D H Sliney
Journal:  Prog Retin Eye Res       Date:  2004-09       Impact factor: 21.198

9.  Light exposure stimulates formation of A2E oxiranes in a mouse model of Stargardt's macular degeneration.

Authors:  Roxana A Radu; Nathan L Mata; Aarti Bagla; Gabriel H Travis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-05       Impact factor: 11.205

10.  Retinal degeneration in a rodent model of Smith-Lemli-Opitz syndrome: electrophysiologic, biochemical, and morphologic features.

Authors:  Steven J Fliesler; Neal S Peachey; Michael J Richards; Barbara A Nagel; Dana K Vaughan
Journal:  Arch Ophthalmol       Date:  2004-08
View more
  27 in total

1.  The Effect of Small Molecules on Sterol Homeostasis: Measuring 7-Dehydrocholesterol in Dhcr7-Deficient Neuro2a Cells and Human Fibroblasts.

Authors:  Zeljka Korade; Hye-Young H Kim; Keri A Tallman; Wei Liu; Katalin Koczok; Istvan Balogh; Libin Xu; Karoly Mirnics; Ned A Porter
Journal:  J Med Chem       Date:  2016-01-29       Impact factor: 7.446

2.  Partial rescue of retinal function and sterol steady-state in a rat model of Smith-Lemli-Opitz syndrome.

Authors:  Steven J Fliesler; Dana K Vaughan; Erin C Jenewein; Michael J Richards; Barbara A Nagel; Neal S Peachey
Journal:  Pediatr Res       Date:  2007-03       Impact factor: 3.756

3.  Pulmonary vein stenosis in patients with Smith-Lemli-Opitz syndrome.

Authors:  Aaron R Prosnitz; Jane Leopold; Mira Irons; Kathy Jenkins; Amy E Roberts
Journal:  Congenit Heart Dis       Date:  2017-07-18       Impact factor: 2.007

4.  Novel oxysterols observed in tissues and fluids of AY9944-treated rats: a model for Smith-Lemli-Opitz syndrome.

Authors:  Libin Xu; Wei Liu; Lowell G Sheflin; Steven J Fliesler; Ned A Porter
Journal:  J Lipid Res       Date:  2011-08-04       Impact factor: 5.922

Review 5.  Retinal light damage: mechanisms and protection.

Authors:  Daniel T Organisciak; Dana K Vaughan
Journal:  Prog Retin Eye Res       Date:  2009-12-03       Impact factor: 21.198

6.  Lipid-derived and other oxidative modifications of retinal proteins in a rat model of Smith-Lemli-Opitz syndrome.

Authors:  Rebecca J Kapphahn; Michael J Richards; Deborah A Ferrington; Steven J Fliesler
Journal:  Exp Eye Res       Date:  2018-08-14       Impact factor: 3.467

7.  7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome.

Authors:  Libin Xu; Lowell G Sheflin; Ned A Porter; Steven J Fliesler
Journal:  Biochim Biophys Acta       Date:  2012-03-09

8.  A reduced zinc diet or zinc transporter 3 knockout attenuate light induced zinc accumulation and retinal degeneration.

Authors:  Shi Bai; Carolyn R Sheline; Yongdong Zhou; Christian T Sheline
Journal:  Exp Eye Res       Date:  2012-12-26       Impact factor: 3.467

9.  Cone ERG responses in patients with Smith-Lemli-Opitz Syndrome (SLOS).

Authors:  Deirdre Garry; Ronald M Hansen; Anne Moskowitz; Ellen R Elias; Mira Irons; Anne B Fulton
Journal:  Doc Ophthalmol       Date:  2010-05-04       Impact factor: 2.379

Review 10.  Treatment of Smith-Lemli-Opitz syndrome and other sterol disorders.

Authors:  Melissa D Svoboda; Jill M Christie; Yasemen Eroglu; Kurt A Freeman; Robert D Steiner
Journal:  Am J Med Genet C Semin Med Genet       Date:  2012-10-05       Impact factor: 3.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.